NYSE:CC Chemours (CC) Stock Price, News & Analysis $10.87 -0.93 (-7.86%) Closing price 11/20/2026 03:59 PM EasternExtended Trading$11.62 +0.75 (+6.85%) As of 11/20/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Chemours Stock (NYSE:CC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Chemours alerts:Sign Up Key Stats Today's Range$10.83▼$11.9250-Day Range$10.87▼$14.9552-Week Range$10.51▼$28.67Volume3.14 million shsAverage Volume2.43 million shsMarket Capitalization$1.64 billionP/E RatioN/ADividend Yield3.22%Price Target$17.36Consensus RatingHold Company Overview The Chemours Company is a global chemicals manufacturer spun off from DuPont in 2015 and headquartered in Wilmington, Delaware. It develops and produces materials used in industries ranging from construction and transportation to electronics and energy. Chemours’ Titanium Technologies business makes titanium dioxide (TiO₂) pigment, sold under the Ti-Pure brand, which is used to add whiteness, brightness and opacity to products such as paints, coatings, plastics and paper. Its Thermal & Specialized Solutions business supplies refrigerants, foam-blowing agents and other specialty fluids, including products marketed under the Opteon and Freon brands. The company also makes fluoropolymers, fluoroelastomers, membranes and related materials through its Advanced Performance Materials business, serving applications in sectors such as automotive, electronics, chemical processing and clean energy.AI Generated. May Contain Errors. Read More Chemours Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks72nd Percentile Overall ScoreCC MarketRank™: 3.61674069961 of 5 starsChemours scored higher than 72% of companies evaluated by MarketBeat, and ranked 115th out of 229 stocks in the materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.0 / 5Analyst RatingHold Consensus RatingChemours has received a consensus rating of Hold. The company's average rating score is 2.08, and is based on no strong buy ratings, 3 buy ratings, 8 hold ratings, and 2 sell ratings.Upside PotentialChemours has a consensus price target of $17.36, representing about 59.7% upside from its current price of $10.87.Amount of Analyst CoverageChemours has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Chemours' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth118.75% Earnings GrowthEarnings for Chemours are expected to grow by 118.75% in the coming year, from $0.80 to $1.75 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Chemours is -10.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Chemours is -10.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioChemours has a P/B Ratio of 10.45. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.75% of the float of Chemours has been sold short.Short Interest Ratio / Days to CoverChemours has a short interest ratio ("days to cover") of 6.85.Change versus previous monthShort interest in Chemours has recently decreased by 2.09%, indicating that investor sentiment is improving. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldChemours pays a meaningful dividend of 2.97%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthChemours does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Chemours will have a dividend payout ratio of 20.00% next year. This indicates that Chemours will be able to sustain or increase its dividend.Read more about Chemours' dividend. News and Social Media1.8 / 5News Sentiment-0.11 News SentimentChemours has a news sentiment score of -0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.35 average news sentiment score of Materials companies.News Coverage This WeekMarketBeat has tracked 44 news articles for Chemours this week, compared to 8 articles on an average week.Search Interest16 people have searched for CC on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Chemours to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Chemours insiders have not sold or bought any company stock.Percentage Held by Insiders0.85% of the stock of Chemours is held by insiders.Percentage Held by Institutions76.26% of the stock of Chemours is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Chemours' insider trading history. Receive CC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CC Stock News HeadlinesThe Chemours Company Securities Fraud Class Action Result of Overstatement of Refrigerant Aftermarket Demand and 18% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLCNovember 20 at 10:00 PM | prnewswire.comSHAREHOLDER ALERT: Bronstein Gewirtz & Grossman, LLC Announces Class Action Against Chemours Company (NYSE: CC) — Investors Who Suffered Losses Are Encouraged to Contact the FirmNovember 20 at 12:00 PM | globenewswire.comThe next convergence is hereIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.November 21 at 1:00 AM | Digest Publishing (Ad)Bragar Eagel & Squire, P.C. Urges The Chemours Company Investors to Contact the Firm Before December 7th Seeking Lead Plaintiff RoleNovember 20 at 11:50 AM | globenewswire.comCC Investors: BFA Law Notifies Chemours Investors with Losses of the Filed Securities Fraud Class Action and Upcoming December 7 Court DeadlineNovember 20 at 6:18 AM | globenewswire.comWhat is Zacks Research's Forecast for Chemours Q1 Earnings?November 20 at 2:12 AM | americanbankingnews.comCC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit with SBS LawNovember 19 at 3:56 PM | prnewswire.comThe Chemours Company Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CCNovember 19 at 3:54 PM | prnewswire.comSee More Headlines CC Stock Analysis - Frequently Asked Questions How have CC shares performed this year? Chemours' stock was trading at $11.76 on January 1st, 2026. Since then, CC stock has decreased by 7.6% and is now trading at $10.8720. How were Chemours' earnings last quarter? The Chemours Company (NYSE:CC) released its earnings results on Monday, November, 2nd. The specialty chemicals company reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.26 by $0.05. Chemours's revenue for the quarter was up 3.0% compared to the same quarter last year. Read the conference call transcript. Who are Chemours' major shareholders? Top institutional shareholders of Chemours include State Street Corp (4.04%), Goldman Sachs Group Inc. (1.89%), Jefferies Financial Group Inc. (1.82%) and American Century Companies Inc. (1.38%). Insiders that own company stock include Denise Dignam, Damian Gumpel, Shane Hostetter, Calderon Gerardo Familiar, Diane I Picho and Alvenia Scarborough. View institutional ownership trends. How do I buy shares of Chemours? Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Chemours own? Based on aggregate information from My MarketBeat watchlists, some other companies that Chemours investors own include NVIDIA (NVDA), Micron Technology (MU), DuPont de Nemours (DD), Pfizer (PFE), AT&T (T), Alibaba Group (BABA) and Advanced Micro Devices (AMD). Company Calendar Record date for 9/15 Dividend8/14/2026Ex-Dividend for 9/15 Dividend8/14/2026Dividend Payable9/15/2026Last Earnings11/02/2026Record date for 12/15 Dividend11/16/2026Ex-Dividend for 12/15 Dividend11/16/2026Today11/21/2026Dividend Payable12/15/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 CC's financial health is in the Red zone, according to TradeSmith. CC has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorMaterials Industry Chemicals Sub-IndustryDiversified Chemicals Current SymbolNYSE:CC CIK1627223 Webwww.chemours.com Phone(302) 773-1000FaxN/AEmployees5,700Year Founded2015Price Target and Rating Average Price Target for Chemours$17.36 High Price Target$30.00 Low Price Target$14.00 Potential Upside/Downside+59.7%Consensus RatingHold Rating Score (0-4)2.08 Research Coverage13 Analysts Profitability EPS (Trailing Twelve Months)($1.02) Trailing P/E RatioN/A Forward P/E Ratio6.21 P/E GrowthN/ANet Income-$386 million Net Margins-2.64% Pretax Margin2.26% Return on Equity76.52% Return on Assets1.51% Debt Debt-to-Equity Ratio24.25 Current Ratio1.81 Quick Ratio0.98 Sales & Book Value Annual Sales$5.84 billion Price / Sales0.28 Cash Flow$2.87 per share Price / Cash Flow3.79 Book Value$1.04 per share Price / Book10.45Miscellaneous Outstanding Shares150,535,000Free Float149,255,000Market Cap$1.64 billion OptionableOptionable Beta1.47 Social Links 7 Stocks That Could Be Bigger Than Tesla, NVIDIA, and GoogleCould the next Tesla, NVIDIA, and Google be hiding in plain sight? Discover seven growth stocks with the potential to become tomorrow's market giants, fueled by breakthroughs in AI, nuclear energy, cybersecurity, and more.Get This Free Report This page (NYSE:CC) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Chemours Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemours With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.